Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-18

Clinical Trial Update: OXXYNEA® GS: Study for Glycaemia Management [NA]

View source ↗

Summary

Fytexia's OXXYNEA GS study for glycemia management in individuals with a prediabetic state is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXXYNEA® GS

Snippet

Sponsor: Fytexia | Conditions: Prediabetic State, Overweight | NA | Status: ACTIVE_NOT_RECRUITING